Researchers used medical imaging, blood work and advanced AI algorithms to examine patient health six months after a mild COVID-19 infection. 

The new survey, organized by the American College of Cardiology, was completed by nearly 6,000 cardiologists from all over the world. 

To build and validate their advanced AI model, researchers explored data from nearly 78,000 TAVR hospitalizations.

Representatives from Google Health, Philips, Samsung, Abbott and Omron have been invited to contribute to the new collaboration. 

The study’s authors developed and validated a new performance measure for TAVR care using data from more than 52,000 patients. They shared their full analysis ahead of print in Circulation.

The singer's family originally filed the lawsuit in November 2018.

Certain patients face a "significantly greater risk of AFib" if they take fish oil supplements, the study's authors reported. 

Young adults who had COVID-19—even those who never had strong symptoms—may go on to have significant cardiovascular issues later in life.

The FDA has approved an AI tool for speeding thyroid sonography workflows while, across the Atlantic, the European Union has OK’d an AI-based ultrasound device that guides nerve blocking as a form of local anesthesia